bioAffinity Technologies (BIAF) Capital Leases (2023 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Capital Leases of $514834.0 for Q1 2026, up 53.27% year-over-year from $335899.0 in Q1 2025, and down 3.36% quarter-over-quarter from $532759.0 in Q4 2025.
bioAffinity Technologies (BIAF) Capital Leases (2023 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Capital Leases for 4 consecutive years, with $514834.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Leases rose 53.27% year-over-year to $514834.0; the TTM figure through Mar 2026 stood at $514834.0 (up 53.27% YoY), while the FY2025 annual figure was $532759.0, up 19.87% from the prior year.
- Capital Leases declined to $514834.0 in Q1 2026 per BIAF's latest filing, from $532759.0 in the prior quarter.
- Across five years, Capital Leases topped out at $929570.0 in Q3 2023 and bottomed at $1998.0 in Q3 2025.
- Historically, Capital Leases has averaged $502088.0 across 4 years, with a median of $532759.0 in 2025.
- Annual changes were most pronounced in 2025 — Capital Leases plunged 99.63% — and 2026, when it jumped 53.27%.
- bioAffinity Technologies' Capital Leases stood at $835467.0 in 2023, then slumped by 46.8% to $444448.0 in 2024, then advanced by 19.87% to $532759.0 in 2025, then decreased by 3.36% to $514834.0 in 2026.
- Business Quant data shows BIAF's Capital Leases at $514834.0 in Q1 2026, $532759.0 in Q4 2025, and $1998.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | bioAffinity Technologies | 2.38 Mn | -721,990.64 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 514,834.00 |
| Dec 31, 2025 | 532,759.00 |
| Sep 30, 2025 | 1,998.00 |
| Jun 30, 2025 | 3,942.00 |
| Mar 31, 2025 | 335,899.00 |
| Dec 31, 2024 | 444,448.00 |
| Sep 30, 2024 | 543,007.00 |
| Jun 30, 2024 | 641,566.00 |
| Mar 31, 2024 | 739,478.00 |
| Dec 31, 2023 | 835,467.00 |
| Sep 30, 2023 | 929,570.00 |